{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is iCAD, Inc. technically bullish or bearish?
As of April 24, 2025, iCAD, Inc. shows a bullish trend supported by positive daily moving averages and bullish weekly MACD and KST, though caution is advised due to a mildly bearish weekly Dow Theory signal.
Who are in the management team of iCAD, Inc.?
As of March 2022, the management team of iCAD, Inc. includes Mr. Michael Klein as Executive Chairman and CEO, along with independent directors Mr. Nathaniel Dalton, Dr. Rakesh Patel, Mr. Andrew Sassine, and Dr. Susan Wood.
What does iCAD, Inc. do?
iCAD, Inc. specializes in advanced image analysis, workflow solutions, and radiation therapy for cancer detection and treatment, with a market cap of USD 104.27 million. As of March 2025, it reported net sales of USD 5 million and a net profit loss of USD 1 million.
How big is iCAD, Inc.?
As of Jun 18, iCAD, Inc. has a market capitalization of 104.27 million and reported net sales of 19.53 million with a net profit of -5.22 million for the latest four quarters. Shareholder's funds are 28.68 million, and total assets amount to 37.54 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
